Results 31 to 40 of about 15,817 (237)

LVAD HRQoL conceptual framework.

, 2022
Conceptual framework based on clusters and statements within identifying key domains and items that are important to LVAD recipients.
Stephen Griffith (2347672), Melanie Calvert (89959), Hoong Sern Lim (8779964), Margaret E. O’Hara (12213475), David Quinn (217019), Anita L. Slade (13840225), Laura Marley (13840228), M. Sayeed Haque (6686093), Philippa Doherty (13840231), Deirdre A. Lane (7937708)   +9 more
core   +1 more source

A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide

Frontiers in Cardiovascular Medicine, 2022
The use of a left ventricular assist device (LVAD) as a bridge-to-transplantation or destination therapy to support cardiac function in patients with end-stage heart failure (HF) is increasing in all developed countries.
Matteo Cameli, Maria Concetta Pastore, Giulia Elena Mandoli, Federico Landra, Matteo Lisi, Matteo Lisi, Luna Cavigli, Flavio D'Ascenzi, Marta Focardi, Chiara Carrucola, Aleksander Dokollari, Gianluigi Bisleri, Charilaos Tsioulpas, Sonia Bernazzali, Massimo Maccherini, Serafina Valente   +15 more
doaj   +1 more source

Patients’ LVAD waveform responses.

, 2020
Patients’ LVAD waveform responses.
Libera Fresiello (4268050), Heinrich Schima (8043344), Christiane Marko (8595759), Christoph Gross (8595750), Dominik Wiedemann (388586), Francesco Moscato (8413617), Martin Maw (8595762), Thomas Schlöglhofer (8595753), Kamen Dimitrov (8595756), Daniel Zimpfer (7900883), Bart Meyns (4268044)   +10 more
core   +1 more source

Association between early ventricular arrhythmias and mortality in destination vs. bridge patients on continuous flow LVAD support

Scientific Reports, 2021
The association between ventricular arrhythmias (VAs) and mortality in patients supported by continuous flow left ventricular assist devices (LVAD) remains controversial.
Zeina Jedeon, Rebecca Cogswell, Jessica Schultz, Lisa Von Wald, Ranjit John, Henri Roukoz   +5 more
doaj   +1 more source

The Effect of Left Ventricular Assist Devices (LVAD) on Pulmonary Hypertension in End-Stage Heart Failure.

, 2021
Despite the increasing prevalence of advanced heart failure, transplantation rates have remained stable in Canada due to limited organ availability. Consequently, the number of implanted left ventricular assist devices (LVAD) and average time on device ...
Tremblay, Philippe
core  

Heart-Failing Jehovah's Witness Patient Successfully Treated by Minimally Invasive LVAD Implantation without Any Blood Transfusions

The Thoracic & Cardiovascular Surgeon Reports, 2015
Left ventricular assist device (LVAD) implantation without the use of any blood products is considered as a challenge. We present a 48-year-old patient (175 cm, 75 kg, body mass index 24.5 kg/m2) who was admitted to our clinic due to end-stage heart ...
Jasmin S. Hanke, Murat Avsar, Axel Haverich, Jan D. Schmitto   +3 more
doaj   +1 more source

Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Type 2 diabetes is prevalent in cardiovascular disease and contributes to excess morbidity and mortality. We sought to investigate the effect of glycemia on functional cardiac improvement, morbidity, and mortality in durable left ventricular ...
Christos P. Kyriakopoulos, Iosif Taleb, Eleni Tseliou, Konstantinos Sideris, Rana Hamouche, Eleni Maneta, Marisca Nelson, Ethan Krauspe, Sean Selko, Joseph R. Visker, Elizabeth Dranow, Matthew L. Goodwin, Rami Alharethi, Omar Wever‐Pinzon, James C. Fang, Josef Stehlik, Craig H. Selzman, Thomas C. Hanff, Stavros G. Drakos   +18 more
doaj   +1 more source

Patient-specific, echocardiography compatible flow loop model of aortic valve regurgitation in the setting of a mechanical assist device

Frontiers in Cardiovascular Medicine, 2023
BackgroundAortic regurgitation (AR) occurs commonly in patients with continuous-flow left ventricular assist devices (LVAD). No gold standard is available to assess AR severity in this setting.
Mahwash Kassi, Stefano Filippini, Eleonora Avenatti, Susan Xu, Susan Xu, Kinan Carlos El-Tallawi, Clara I. Angulo, Marija Vukicevic, Marija Vukicevic, Stephen H. Little   +9 more
doaj   +1 more source

Similar changes in miR expression in pulsatile flow (pf-LVAD) and continuous flow LVAD (cf-LVAD).

, 2015
The alteration in miR-expression in myocardial tissue of both pf-LVAD (n = 17) and cf-LVAD (n = 17) patients. miR-129* (a) and miR-146a (b) are up-regulated in post-LVAD in comparison to pre-LVAD, whereas miR- 155 (c), miR-221 (d) and miR-222 (e) are ...
Nicolaas de Jonge (551513), Ankie J. P. van Geffen (802772), Bjorn Winkens (474672), Erica Siera (802775), Manon M. H. Huibers (802773), Roel A. de Weger (551515), Paula A. da Costa Martins (318745), Petra van der Weide (802774), Pieter A. Doevendans (137859), Joyce van Kuik (802771), Sjoukje I. Lok (383140)   +10 more
core   +1 more source

Baseline demographics of the patients supported with a pulsatile flow LVAD (pf-LVAD) and continuous flow LVAD (cf-LVAD) (validation).

, 2015
HF, heart failure; CVA, cerebrovascular accident; TIA, transient ischemic attack; NYHA, New York Heart Association; DCM, dilated cardiomyopathy; CRTD, cardiac resynchronization therapy defibrillator; ICD, implantable cardioverter defibrillator ...
Nicolaas de Jonge (551513), Ankie J. P. van Geffen (802772), Bjorn Winkens (474672), Erica Siera (802775), Manon M. H. Huibers (802773), Roel A. de Weger (551515), Paula A. da Costa Martins (318745), Petra van der Weide (802774), Pieter A. Doevendans (137859), Joyce van Kuik (802771), Sjoukje I. Lok (383140)   +10 more
core   +1 more source